You are here:Home-Chemical Inhibitors & Agonists-Epigenetics-Bromodomain-ABBV-744
ABBV-744

Chemical Structure : ABBV-744

CAS No.: 2138861-99-9

ABBV-744 (ABBV744)

Catalog No.: PC-35172Not For Human Use, Lab Use Only.

ABBV-744 (ABBV744) is a highly potent and selective inhibitor of the BD2 domain of BET family proteins with IC50 of 4-18 nM for BD2 of BRD2, BRD3, BRD4 and BRDT.

Packing Price Stock Quantity
10 mg $158 In stock
25 mg $278 In stock
50 mg $458 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

ABBV-744 (ABBV744) is a highly potent and selective inhibitor of the BD2 domain of BET family proteins with IC50 of 4-18 nM for BD2 of BRD2, BRD3, BRD4 and BRDT.
ABBV-744 displayed >250-fold differential binding preference for BDII over BDI and excellent drug-like properties.
ABBV-744 inhibited SARS-CoV-2 replication in Syrian hamsters, potently blocked endogenous ACE2 expression and SARS-CoV-2 infection of human cells, highlighting the potential of BRD2 as a novel therapeutic target for COVID-19.
ABBV-744 displayed significant antiproliferative activities largely although not exclusively in cancer cell lines derived from acute myeloid leukemia and androgen receptor positive prostate cancer.
ABBV-744 demonstrated antitumor efficacy in acute myeloid leukemia xenograft models with an improved therapeutic index compared with the pan-BET inhibitor ABBV-075. enhanced the antitumor efficacy of BCL-2 inhibitor, venetoclax.

Physicochemical Properties

M.Wt 491.563
Formula C28H30FN3O4
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

1H-Pyrrolo[2,3-c]pyridine-2-carboxamide, N-ethyl-4-[2-(4-fluoro-2,6-dimethylphenoxy)-5-(1-hydroxy-1-methylethyl)phenyl]-6,7-dihydro-6-methyl-7-oxo-

References

1. Faivre EJ, et al. Nature. 2020 Feb;578(7794):306-310.
2. Sheppard GS, et al. J Med Chem. 2020 May 28;63(10):5585-5623.
3. Fakhar Z, et al. Sci Rep. 2021 Jan 8;11(1):234.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: